TMEM59L remained significant after adjusting for age and gender but lost significance after stage adjustment (HR = 1.145, p = 0.457), suggesting the prognostic effect may be mediated by tumor stage (Figure 1D). This evidence concerns the gene TMEM59L and neoplasm.